Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.

Ahmann A, Rodbard HW, Rosenstock J, Lahtela JT, de Loredo L, Tornøe K, Boopalan A, Nauck MA, NN2211-3917 Study Group.

Open source

DOI
10.1111/dom.12539
Published
2015-09-10
Container
Diabetes Obes Metab
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.12539,
  title = {Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.},
  author = {Ahmann A and  Rodbard HW and  Rosenstock J and  Lahtela JT and  de Loredo L and  Tornøe K and  Boopalan A and  Nauck MA and  NN2211-3917 Study Group.},
  year = {2015},
  journal = {Diabetes Obes Metab},
  doi = {10.1111/dom.12539},
  url = {https://doi.org/10.1111/dom.12539}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.
AU  - Ahmann A
AU  -  Rodbard HW
AU  -  Rosenstock J
AU  -  Lahtela JT
AU  -  de Loredo L
AU  -  Tornøe K
AU  -  Boopalan A
AU  -  Nauck MA
AU  -  NN2211-3917 Study Group.
PY  - 2015
JO  - Diabetes Obes Metab
DO  - 10.1111/dom.12539
UR  - https://doi.org/10.1111/dom.12539
ER  - 

APA

A, A., HW, R., J, R., JT, L., L, D. L., K, T., A, B., MA, N., & Group., N. S. (2015). Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.. Diabetes Obes Metab. https://doi.org/10.1111/dom.12539

Source records